ArticleAnnals of clinical epidemiology2023

Antiviral medications for mild-to-moderate COVID-19 in Japan: a gap of timing between clinical trials and real-world scenarios in a fast-changing pandemic.

Sugihiro Hamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.